Peripheral analgesic sites of action of anti-inflammatory drugs

International Journal of Clinical Practice, Supplement

Volumn , Issue 128, 2002, Pages 2-10

  Ferreira, S H ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

cAMP; cGMP; Corticoid analgesia; COX inhibitors; Direct blockade of nociceptor hypersensitisation; Eicosanoids; Hyperalgesia; Hyperalgesic cytokines; Hypersensitisation memory; Nitric oxide; Nociceptor hypersensitisation

Indexed keywords

ANTIINFLAMMATORY AGENT; BRADYKININ; CALCIUM ION; COMPLEMENT COMPONENT C3A; COMPLEMENT COMPONENT C5A; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC GMP; CYTOKINE; DICLOFENAC; DIPYRONE; ENDOTHELIN; FLURBIPROFEN; GLUCOCORTICOID; HISTAMINE; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; LEUKOTRIENE B4; NIMESULIDE; PROSTACYCLIN; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE; PROTEIN KINASE C; SEROTONIN; TUMOR NECROSIS FACTOR; UNINDEXED DRUG; NONSTEROID ANTIINFLAMMATORY AGENT;

ANALGESIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; CONFERENCE PAPER; HUMAN; HYPERALGESIA; IMMUNOPATHOGENESIS; INFLAMMATION; NEUROMODULATION; NOCICEPTION; NONHUMAN; PAIN; PRIORITY JOURNAL; RECEPTOR SENSITIVITY; ANALGESIA; BIOLOGICAL MODEL; DRUG EFFECT; IMMUNOLOGY; MACROPHAGE; NEUTROPHIL; NOCICEPTIVE RECEPTOR; PHYSIOLOGY; REVIEW;

ANALGESIA; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CYTOKINES; HUMANS; HYPERALGESIA; INFLAMMATION; MACROPHAGES; MODELS, IMMUNOLOGICAL; NEUTROPHILS; NOCICEPTORS;

EID: 0035984657     PISSN: 1368504X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (47)

1. Role of inducible forms of cyclooxygenase and nitric oxide synthase in inflammatory pain
2. The pivotal role of tumour necrosis factor alpha in the development of inflammatory hyperalgesia
3. Blocking IL-1: Interleukin-1 receptor antagonist in vivo and in vitro
4. Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist
5. Interleukin-1 receptor antagonist competitively inhibits the binding of interleukin-1 to the type II interleukin-1 receptor
6. Interleukin 1 (IL-1) gene expression, synthesis, and effect of specific IL-1 receptor blockade in rabbit immune complex colitis
7. Interleukin-1 receptor antagonist reduces mortality from endotoxin shock
8. Expression of leukocyte alkaline phosphatase gene in normal and leukemic cells: Regulation of the transcript by granulocyte colony-stimulating factor
9. Pro-and anti-inflammatory roles of interleukin-1 in recurrence of bacterial cell wall-induced arthritis in rats
10. Increase of p75 immunoreactivity in rat urinary bladder following inflammation
11. Gingival crevicular interleukin-1 and interleukin-1 receptor antagonist levels in periodontally healthy and diseased sites
12. The role of the vagus nerve in cytokine-to-brain communication
13. Tumour necrosis factor-α mediates carrageenin-induced knee-joint incapacitation and also triggers overt nociception in previously inflamed rat knee-joints
14. Involvement of resident macrophages and mast cells in the writhing nociceptive response induced by zymosan and acetic acid in mice
15. In vivo inhibition of PMN migration by antimacrophage serum
16. Nerve growth factor induced hyperalgesia in the rat hind paw is dependent on circulating neutrophils
17. Peripheral cell types contributing to the hyperalgesic action of nerve growth factor in inflammation
18. Rat knee-joint carrageenin incapacitation test: An objective screen for central and peripheral analgesics
19. Interleukin-1 beta as a potent hyperalgesic agent antagonized by a tripeptide analogue
20. Pain and inflammation
21. Sensitisaton of nociceptors and its relation to sensation
22. Novel classes of nociceptors: Beyond Sherrington
23. What is a nociceptor?
24. 2+ dependent process
25. Inhibition of forskolin-induced sensitisation of frog skin nociceptors by the cyclic AMP-dependent protein kinase A antagonist H-89
26. Mediation of primary afferent peripheral hyperalgesia by the cAMP second messenger system
27. Activation of ATP-sensitive K(+) channels: Mechanism of peripheral antinociceptive action of the nitric oxide donor, sodium nitroprusside
28. The peripheral antinociceptive effect induced by morphine is associated with ATP-sensitive K(+) channels
29. Glutamate spinal retrograde sensitization of primary sensory neurons associated with nociception
30. Peripheral analgesia and activation of the nitric oxide-cyclic GMP pathway
31. Effects of intrathecal L- and N-type calcium channel blockers on the antinociception evoked by opioid agonists in the rat tail flick test
32. Mechanism of diclofenac analgesia: Direct blockade of inflammatory sensitization
33. Activation of the arginine-nitric oxide pathway in primary sensory neurons contributes to dipyrone-induced spinal and peripheral analgesia
34. Analgesia by direct antagonism of nociceptor sensitization involves the arginine-nitric oxide-cGMP pathway
35. Molecular base of acetylcholine and morphine analgesia
36. cGMP mediates the vascular and platelet actions of nitric oxide: Confirmation using an inhibitor of the soluble guanylyl cyclase
37. Evidence for the involvement of the nitric oxide-cGMP pathway in the antinociception of morphine in the formalin test
38. 2
39. Induction, blockade and restoration of a persistent hypersensitive state
40. Is methylnalorphinium the prototype of an ideal peripheral analgesic?
41. Mode of analgesic action of dipyrone: Direct antagonism of inflammatory hyperalgesia
42. Persistent hyperalgesia and cytokines
43. Direct blockade of inflammatory hyperalgesia by nitric oxide analgesics
44. Antinociceptive actions of R(-)-flurbiprofen - A non-cyclooxygenase inhibiting 2-aryl-propionic acid - In rats
45. The role of interleukins and nitric oxide in the mediation of inflammatory pain and its control by peripheral analgesics
46. A reduction of tumor necrosis factor-alpha in paw exudate of lipopolysaccharide treated rats by nimesulide
47. Evidence for the participation of the nitric oxide-cyclic GMP pathway in the antinociceptive effect of nimesulide